A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho
Completed · Not applicable · NCT04598958
Conditions: Human Immunodeficiency Virus
At a glance
- Research payments reported, 2025
- $4.4M
- U.S. investigators named
- 5
- Sites paid
- 5
- Planned or actual enrollment
- 1,004
About the trial
- Sponsor
- Elizabeth Glaser Pediatric AIDS Foundation (with Ministry of Health, Lesotho, United States Agency for International Development (USAID), Avenir Health, Population Council, Johns Hopkins University)
- Tested
- IMPROVE (other)
- Dates
- Started 2016-07-27; completion 2020-09-30
- Results posted
- Not yet
This study aims to improve maternal and child health (MCH) outcomes by implementing and evaluating a multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" intervention to increase MCH, antiretroviral therapy (ART), and HIV services uptake and retention in Lesotho. The proposed intervention will focus efforts to improve the effectiveness of existing village health workers (VHW) and HIV support organizations (Lesotho Network of AIDS Service Organizations \[LENASO\] and Mothers2Mothers \[M2M\]) based at the facility and coordination between the facility and community. The IMPROVE intervention includes: (1) Multidisciplinary integrated management teams to…
From ClinicalTrials.gov, last updated 2020-10-22. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Philips North America LLC reported $4.4M in research payments for this study in 2025 (12 payments).
Products named: Eagle Eye
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Ehtisham Mahmud, M.D. Interventional Cardiology · San Diego, CA
- Jeffrey M. Zimmet, M.D. Interventional Cardiology · San Francisco, CA
- Ron Waksman, M.D. Interventional Cardiology · Washington, DC
- Nauman Khalid, MD Interventional Cardiology · Monroe, LA
- Scott A. Mikesell, DO Interventional Cardiology · Duluth, MN
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Medstar Health Research Institute $4.4M
- Franciscan Missionaries of Our Lady Health System $12,870
- University of California San Diego Jacobs Medical Center $7,865
- Sfva $4,620
- St Lukes Hospital, MN $715
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.